WATCH NOW
Lexeo Therapeutics | May 2026
On May 4, 2026, Dr. Ron Crystal, Professor and Chairman of the Department of Genetic Medicine at Weill Cornell Medicine, and Nilomi Shah, PharmD, Lexeo Therapeutics, joined FARA for a webinar titled Safety and Preliminary Efficacy of AAVrh.10hFXN (LX2006) Gene Therapy in Friedreich Ataxia Cardiomyopathy. This webinar provided an update on the 12-month data from the first phase of this gene therapy clinical trial.
